Maxalt RPD

Medicinal product

(Invented) name

Maxalt RPD

Active substance (s)

Rizatriptanas

Strength

10 mg

Pharmaceutical form

geriamasis liofilizatas

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC04, Rizatriptan

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2025-12-18

Date of renewal

Documents

3086_Maxalt RPD 10 mg geriamasis liofilizatas_PZ_2025-12-18.docx

3086_Maxalt RPD 10 mg geriamasis liofilizatas_PL_2025-12-18.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Geriamajame liofilizate yra:	1 vnt.
Rizatriptanas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119543	105649	1105649	lizdinė plokštelė	N3		Receptinis	LT/L/25/3086/001	Netiekiama	-	2026-07-01	No	-	-	Download
119544	105650	1105650	lizdinė plokštelė	N6		Receptinis	LT/L/25/3086/002	Netiekiama	-	2026-07-01	No	-	-

Stadijos

Data	Stadija
2025-12-18	Registruotas